GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.42
Tradestie Score
64
Market Cap
$899.60M
Revenue Growth
0.3%
Analyst Upside
+139.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$7.74
|
$997.16M | - | 55 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.52
|
$996.55M | - | 58 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$93.73
|
$994.20M | - | 62 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.26
|
$993.46M | - | 62 | Compare |
|
IMNM
Immunome, Inc.
|
$22.80
|
$987.09M | - | 62 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$8.52
|
$952.74M | - | 58 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.64
|
$951.83M | - | 61 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$27.88
|
$931.48M | - | 62 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.73
|
$917.23M | - | 64 | Compare |
More GERN Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry